Avalon Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$170K Hold
1,140
– – 0.01% 161
2026
Q2
$144K Hold
1,140
– – 0.01% 176
2026
Q1
$159K Sell
1,140
-18
-2% -$2.52K 0.01% 168
2025
Q4
$142K Sell
1,158
-100
-8% -$12.2K 0.01% 172
2025
Q3
$140K Buy
1,258
+118
+10% +$13.4K 0.01% 193
2025
Q2
$126K Buy
+1,140
New +$121K 0.01% 175

Other funds holding GILD

Avalon Trust's GILD Position: Q3 2026 in Review

Avalon Trust held its Gilead Sciences (GILD) position steady in Q3 2026 at 1,140 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #161.

Avalon Trust first reported a position in GILD in Q2 2025 and has held it in 6 quarters since. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Avalon Trust held 1,140 shares of Gilead Sciences worth $170K as of Q3 2026.
  • Avalon Trust left its Gilead Sciences share count unchanged in Q3 2026.
  • Gilead Sciences made up 0.01% of Avalon Trust's portfolio in Q3 2026, its #161 holding.
  • Avalon Trust first reported a position in Gilead Sciences in Q2 2025 and has held it in 6 quarters since.
  • 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Avalon Trust's 13F filing for Q3 2026, filed 13 Nov 2026.